4.7 Article

New fluorine-containing hydrazones active against MDR-tuberculosis

Journal

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 46, Issue 10, Pages 4937-4945

Publisher

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2011.07.052

Keywords

Tuberculosis; Multidrug-resistant tuberculosis; Hydrazone; Antitubercular drug; In vitro activity

Funding

  1. Hungarian National Science Fund [OTKA 68358]
  2. National Office for Research and Technology [NKFP_07_1-TB_INTER-HU]
  3. Slovenian Reasearch Agency [P1-0230-103, BI-CZ/10-11-005]
  4. EN-FIST Centre of Excellence, Ljubljana, Slovenia
  5. [MSM 0021620822]
  6. [IGA NS 10367-3]

Ask authors/readers for more resources

Several new fluorine-containing hydrazones were synthesized and screened for their in vitro anti-mycobacterial activity. Nine of these derivatives have shown a remarkable activity against MDR-TB strain with MIC 0.5 mu g/mL and high value of selectivity index (SI). Compound 3h with the highest SI (1268.58) was used for stability evaluation with putative metabolites (ciprofloxacin and formylciprofloxacin) detection. Compound 3h was stable at pH 7.4 of aqueous buffer and rat plasma, in acidic buffers (at pH 3 and 5) slow decomposition was observed. Interestingly, no formylciprofloxacin was detected in the solution, and only slightly increased concentration of ciprofloxacin was observed instead. Trifluoromethyl hydrazones 3f and 3g exhibited the best activity also against two strains of Mycobacterium kansasii (MIC 1-4 mu mol/L). All evaluated compounds were found to be non-cytotoxic. (C) 2011 Elsevier Masson SAS. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available